Comparison of physical properties and drug-releasing characteristics of white petrolatums

Pharmazie

Volumn 65, Issue 11, 2010, Pages 801-804

  Ogita, Y ^a   Takahashi, Yuri ^b   Iwata, M ^b   Sasatsu, M ^c   Onishi, H ^c   Hashimoto, S ^a   Machida, Y ^c  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

^c HOSHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COSMETIC; FLUORESCEIN ISOTHIOCYANATE; TETRACYCLINE; WHITE PETROLATUM;

ARTICLE; COMPARATIVE STUDY; DIFFUSION; DRUG DISTRIBUTION; DRUG RELEASE; IN VITRO STUDY; OINTMENT; PHYSICAL CHEMISTRY;

ALGORITHMS; DIFFUSION; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; INDICATORS AND REAGENTS; OINTMENT BASES; OINTMENTS; PETROLATUM; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; VISCOSITY;

EID: 78649610048     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.0120     Document Type: Article

References (13)

1. Czerwinski SE, Skvorak JP, Maxwell DM, Lenz DE, Baskin SI (2006) Effect of octanol:water partition coefficients of organophosphorus compounds on biodistribution and percutaneous toxicity. J Biochem Mol Toxicol 20: 241-246.
2. Dooms-Goossens A, Degreef H (1983) Contact allergy to petrolatums (I). Sensitizing capacity of different brands of yellow and white petrolatums. Contact Dermatitis 9: 175-185.
3. Fukami T, Yamamoto Y, Nakamura Y, Kamano M, Umeda Y, Makimura M, Furuishi T, Suzuki T, Tomono K (2006) Quality testing of steroidal ointment mixed with white petrolatum: rheological properties and stability testing. Jpn J Pharm Health Care Sci 32: 964-969.
4. Funke AP, Gunther C, Muller RH, Lipp R (2002) In-vitro release and transdermal fluxes of a highly lipophilic drug and of enhancers from matrix TDS. J Control Release 82: 63-70.
5. Ichikawa I (1977) Easy sciences for paper, ink, print. Insatsu Choyokai Foundation, Tokyo, p. 133-135.
6. Ishizaki S, Fujimaru T, Takano M (1984) Pharmaceutical evaluation on spreading property of marketed corticosteroid ointment and cream. JJSHP 20: 955-958.
7. Kizu J, Ichihara W, Tomonaga E, Abe J, Watanabe T, Inoue T, Hori S (2004) Survey of mixing commercially available corticosteroid ointments with other ointments and the anti-inflammatory activity of the admixtures. Yakugaku Zasshi 124: 93-97.
8. Lien E, Koda RT, Tong GL (1971) Physicochemical properties, bioavailability of drugs: buccal and percutaneous absorption. Drug Intell Clin Pharm 5: 38-41.
9. Nicoli S, Zani F, Bilzi S, Bettini R, Santi P (2008) Association of nicotinamide with parabens: effect on solubility, partition and transdermal permeation. Eur J Pharm Biopharm 69: 613-621.
10. Ogita Y, Takahashi Y, Honda T, Kikkawa Y, Machida Y, Sudo H (2007) Comparison of quality characteristics of white petrolatums. Jpn J Pharm Health Care Sci 33: 613-618.
11. Ohtani M, Yamada N, Takayama K, Kotaki H, Etoh T, Kariya S, Uchino K, Iga T (2002a) Effect of admixture of commercially available corticosteroid ointments and/or creams on vasoconstrictor activity. Yakugaku Zasshi 122: 107-112.
12. Ohtani M, Kotaki H, Kariya S, Uchino K, Iga T (2002b) Evaluation of the permeability of corticosteroid in hairless mouse and hairless micropig skin from admixture of commercially available corticosteroid ointments and/or creams. Yakugaku Zasshi 122: 589-594.
13. Yasuno N, Tsuchiya M, Kizu J, Uzu S, Hasegawa Y, Ono H, Okuda O, Tejima Y (1996) Preparation and clinical application of 2% ethenzamide oral ointment. Jpn J Hosp Pharm 22: 556-563.